AVIR
Atea Pharmaceuticals, Inc. · Healthcare
President, CEO and Chair Jean-Pierre Sommadossi sold $234K of Atea Pharmaceuticals, Inc.
Sold$234,155
$4.04Price
57,969Shares
−1%Stake
What AVIR did after the filing
- The stock from Fri, Sep 20 open, $3.71
- −11.3%
- S&P 500, same days
- +0.6%
Measured over 30 trading days, to the Nov 1 close.
Traded Tue, Sep 17. Filed Thu, Sep 19, 4:02 PM ET, after the close. Returns use the Sep 20 open and the Nov 1 close. Not investment advice.